Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 8/20 | 0.44 |
| ▸ | MTNR1B | P49286 | 8/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | ANPEP | P15144 | 3/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.37 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.37 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.37 |
| ▸ | KDM1A | O60341 | 4/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29516700 | 1.00 | MTNR1A (0.44) | MTNR1AMTNR1BHTR2ACYP3A4TSHR | |
| SCHEMBL29516800 | 1.00 | MTNR1A (0.44) | MTNR1AMTNR1BHTR2ACYP3A4TSHR | |
| SCHEMBL7887852 | 1.00 | MTNR1A (0.44) | MTNR1AMTNR1BHTR2ACYP3A4TSHR | |
| SCHEMBL2244164 | 1.00 | MTNR1A (0.44) | MTNR1AMTNR1BHTR2ACYP3A4TSHR | |
| Hydrochloric Acid SCHEMBL10785087 | 0.98 | MTNR1A (0.43) | MTNR1AMTNR1BHTR2ACYP3A4TSHR | |
| Hydrochloric Acid SCHEMBL2242431 | 0.98 | MTNR1A (0.43) | MTNR1AMTNR1BHTR2ACYP3A4TSHR | |
| Bromide SCHEMBL8715151 | 0.98 | MTNR1A (0.43) | MTNR1AMTNR1BHTR2ACYP3A4TSHR | |
| Acetic Acid SCHEMBL9983815 | 0.88 | MTNR1A (0.54) | MTNR1AMTNR1B | |
| Acetic Acid SCHEMBL9983822 | 0.88 | MTNR1A (0.54) | MTNR1AMTNR1B | |
| SCHEMBL7883609 | 0.80 | ADRA2A (0.49) | MTNR1AMTNR1BCYP3A4TSHRANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023101060-A1 | QUANTUM DOTS AND METHOD FOR PRODUCING SAME | 주식회사 제우스 | 2023-06-08 | — | — | WO | claimed |
| CN-107466322-B | Mutant transaminases and methods and uses related thereto | 豪夫迈·罗氏有限公司 | 2022-04-15 | — | — | CN | claimed |
| EP-3283622-B1 | MUTANT TRANSAMINASES AS WELL AS METHODS AND USES RELATING THERETO | HOFFMANN LA ROCHE (CH) | 2019-07-03 | — | — | EP | claimed |
| US-10017749-B2 | Mutant transaminases as well as methods and uses relating thereto | HOFFMAN-LA ROCHE INC. (US) | 2018-07-10 | — | — | US | claimed |
| CN-108128844-A | A kind of Modification of Montmorillonite material and its preparation method and application | 郑州源冉生物技术有限公司 | 2018-06-08 | — | — | CN | claimed |
| CN-107466322-A | Saltant type transaminase and relative method and purposes | 豪夫迈·罗氏有限公司 | 2017-12-12 | — | — | CN | claimed |
| CN-104353127-B | Composite antibacterial material of graphene quantum dot and fibroin, preparation and application | 中国科学院上海微系统与信息技术研究所 | 2017-01-25 | — | — | CN | claimed |
| US-20160304843-A1 | MUTANT TRANSAMINASES AS WELL AS METHODS AND USES RELATING THERETO | HOFFMANN-LA ROCHE INC. (US) | 2016-10-20 | — | — | US | claimed |
| CN-104557597-A | Clean production method of 3-(N,N-di-substituted)aminoacetanilide compounds | ZHEJIANG LONGSHENG GROUP CO | 2015-04-29 | — | — | CN | claimed |
| CN-104353127-A | Composite antibacterial material of graphene quantum dot and fibroin, preparation and application | SHANGHAI INST MICROSYS & INF | 2015-02-18 | — | — | CN | claimed |
| CN-103525952-B | Method for removing 2-aminoacetophenone in high fructose corn syrup | SHANDONG SCENTS JIANYUAN BIO TECH CO LTD | 2014-11-05 | — | — | CN | claimed |
| CN-103642494-A | Preparation method for fluorescence carbon-based quantum dot | SHANGHAI INST MICROSYS & INF | 2014-03-19 | — | — | CN | claimed |
| CN-103525952-A | Method for removing 2-aminoacetophenone in high fructose corn syrup | SHANDONG SCENTS JIANYUAN BIO TECH CO LTD | 2014-01-22 | — | — | CN | claimed |
| CN-101281366-A | Light-sensitive polymer composition not easy to change color and application thereof | MURAKAMI KUNSHAN PREC STENCIL (CN) | 2008-10-08 | — | — | CN | claimed |
| CN-101281370-A | Photosensitive resin composition with low surface adhesion and application thereof | MURAKAMI KUNSHAN PREC STENCIL (CN) | 2008-10-08 | — | — | CN | claimed |
| CN-1012959-B | PROCESS FOR PREPARATION OF BENZODIAZEPINE | TROPONIVERKE GMBH & CO KG KOEL (DE) | 1991-06-26 | — | — | CN | claimed |
| EP-0179631-B1 | N6-ACENAPHTHYL ADENOSINES AND ANALOGS THEREOF | WARNER-LAMBERT COMPANY (US) | 1989-04-26 | — | — | EP | claimed |
| EP-0179631-A2 | N6-acenaphthyl adenosines and analogs thereof | WARNER-LAMBERT COMPANY (US) | 1986-04-30 | — | — | EP | claimed |
| WO-2023101060-A1 | QUANTUM DOTS AND METHOD FOR PRODUCING SAME | 주식회사 제우스 | 2023-06-08 | — | — | WO | disclosed |
| US-3950347-A | NAPHTHOLACTAM DYESTUFFS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10017749-B2 | Mutant transaminases as well as methods and uses relating thereto | GOT1, GOT2, OAT | MTNR1A 3655/4885MTNR1B 3823/4885HTR2A 4276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.